RECOMBINANT ANTIBODIES AND IMUNOCONJUGATES TARGETED TO CD-22 BEARING CELLS AND TUMORS
Belgium
98912977.0
Filed on 1998-03-19
98912977.0
Filed on 1998-03-19
RECOMBINANT ANTIBODIES AND IMUNOCONJUGATES TARGETED TO CD-22 BEARING CELLS AND TUMORS
Austria
98912977.0
Filed on 1998-03-19
98912977.0
Filed on 1998-03-19
RECOMBINANT ANTIBODIES AND IMUNOCONJUGATES TARGETED TO CD-22 BEARING CELLS AND TUMORS
United Kingdom
98912977.0
Filed on 1998-03-19
98912977.0
Filed on 1998-03-19
RECOMBINANT ANTIBODIES AND IMUNOCONJUGATES TARGETED TO CD-22 BEARING CELLS AND TUMORS
Spain
98912977.0
Filed on 1998-03-19
98912977.0
Filed on 1998-03-19
RECOMBINANT ANTIBODIES AND IMUNOCONJUGATES TARGETED TO CD-22 BEARING CELLS AND TUMORS
Italy
98912977.0
Filed on 1998-03-19
98912977.0
Filed on 1998-03-19
RECOMBINANT ANTIBODIES AND IMUNOCONJUGATES TARGETED TO CD-22 BEARING CELLS AND TUMORS
France
98912977.0
Filed on 1998-03-19
98912977.0
Filed on 1998-03-19
RECOMBINANT ANTIBODIES AND IMUNOCONJUGATES TARGETED TO CD-22 BEARING CELLS AND TUMORS
Germany
98912977.0
Filed on 1998-03-19
98912977.0
Filed on 1998-03-19
RECOMBINANT ANTIBODIES AND IMUNOCONJUGATES TARGETED TO CD-22 BEARING CELLS AND TUMORS
Switzerland
98912977.0
Filed on 1998-03-19
98912977.0
Filed on 1998-03-19
Immunogenicity Using a Combination of DNA and Vaccinia Virus Vector Vaccines
US Patent 7,771,729
Filed on 2006-07-05
Filed on 2006-07-05
Novel Thiolesters and Uses Thereof
Ireland
99930428.0
Filed on 1999-06-18
99930428.0
Filed on 1999-06-18